NA
ARCT icon

NewEdge Advisors’s Arcturus Therapeutics ARCT Stock Holding History

NewEdge Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26
Closed -$479 – 4215
2025
Q3 		$479 Hold
26
– – ﹤0.01% 3953
2025
Q2 		$338 Hold
26
– – ﹤0.01% 3842
2025
Q1 		$275 Hold
26
– – ﹤0.01% 3775
2024
Q4 		$441 Hold
26
– – ﹤0.01% 3672
2024
Q3 		$603 Hold
26
– – ﹤0.01% 3585
2024
Q2 		$633 Hold
26
– – ﹤0.01% 3540
2024
Q1 		$878 Hold
26
– – ﹤0.01% 3522
2023
Q4 		$820 Hold
26
– – ﹤0.01% 3489
2023
Q3 		$664 Hold
26
– – ﹤0.01% 3221
2023
Q2 		$746 Hold
26
– – ﹤0.01% 3283
2023
Q1 		$623 Hold
26
– – ﹤0.01% 3218
2022
Q4 		$0 Buy
+26
New +$453 ﹤0.01% 4085

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return